From: Calmodulin levels in blood cells as a potential biomarker of Alzheimer’s disease
Number | Age | Gender | |||
---|---|---|---|---|---|
Mean | Age range | Male | Female | ||
Lymphoblasts | |||||
HC | 33 | 64 ± 13 | (31 to 83) | 12 | 21 |
MCI | 8 | 73 ± 6 | (62 to 82) | 4 | 4 |
AD | |||||
Total | 35 | 75 ± 7 | (59 to 90) | 16 | 19 |
Mild | 18 | 76 ± 6 | (60 to 83) | 8 | 10 |
Moderate | 10 | 76 ± 7 | (59 to 84) | 4 | 6 |
Severe | 7 | 73 ± 10 | (60 to 90) | 4 | 3 |
FTD | 7 | 64 ± 6 | (54 to 70) | 0 | 7 |
DLB | 4 | 73 ± 15 | (58 to 91) | 3 | 1 |
PD | 20 | 69 ± 10 | (49 to 83) | 14 | 6 |
ALS | 10 | 63 ± 10 | (47 to 79) | 6 | 4 |
PSP | 5 | 79 ± 6 | (72 to 85) | 1 | 4 |
Peripheral blood mononuclear cells | |||||
HC | 15 | 68 ± 8.3 | (57 to 81) | 4 | 11 |
MCI | 7 | 68 ± 7.6 | (55 to 76) | 4 | 3 |
AD | |||||
Total | 21 | 77 ± 9 | (58 to 88) | 9 | 12 |
Mild | 10 | 73 ± 9 | (60 to 85) | 5 | 5 |
Moderate | 10 | 79 ± 8 | (58 to 86) | 4 | 6 |
Severe | 1 | 88 | 88 | 0 | 1 |